Literature DB >> 11072063

RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA.

A Chester1, J Scott, S Anant, N Navaratnam.   

Abstract

RNA editing is a post-transcriptional process that changes the informational capacity within the RNA. These processes include alterations made by nucleotide deletion, insertion and base conversion. A to I and C to U conversion occurs in mammals and these editing events are catalysed by RNA binding deaminases. C to U editing of apoB mRNA was the first mammalian editing event to be identified. The minimal protein complex necessary for apoB mRNA editing has been determined and consists of APOBEC-1 and ACF. Overexpression of APOBEC-1 in transgenic animals caused liver dysplasia and APOBEC-1 has been identified in neurofibromatosis type 1 tumours, suggesting that RNA editing may be another mechanism for tumourigenesis. Several APOBEC-1-like proteins have been identified, including a family of APOBEC-1-related proteins with unknown function on chromosome 22. This review summarises the different types of RNA editing and discusses the current status of C to U apoB mRNA editing. This knowledge is very important in understanding the structure and function of these related proteins and their role in biology.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11072063     DOI: 10.1016/s0167-4781(00)00219-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  35 in total

Review 1.  An overview of cytidine deaminases.

Authors:  Naveenan Navaratnam; Rizwan Sarwar
Journal:  Int J Hematol       Date:  2006-04       Impact factor: 2.490

2.  Large-scale detection of in vivo transcription errors.

Authors:  Jean-François Gout; W Kelley Thomas; Zachary Smith; Kazufusa Okamoto; Michael Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-28       Impact factor: 11.205

Review 3.  The current structural and functional understanding of APOBEC deaminases.

Authors:  Ronda Bransteitter; Courtney Prochnow; Xiaojiang S Chen
Journal:  Cell Mol Life Sci       Date:  2009-06-23       Impact factor: 9.261

Review 4.  Genome Editing with mRNA Encoding ZFN, TALEN, and Cas9.

Authors:  Hong-Xia Zhang; Ying Zhang; Hao Yin
Journal:  Mol Ther       Date:  2019-01-25       Impact factor: 11.454

5.  Hippocampal Characteristics and Invariant Sequence Elements Distribution of GLRA2 and GLRA3 C-to-U Editing.

Authors:  Philipp Schaefermeier; Sarah Heinze
Journal:  Mol Syndromol       Date:  2016-12-16

6.  Biochemical activities of highly purified, catalytically active human APOBEC3G: correlation with antiviral effect.

Authors:  Yasumasa Iwatani; Hiroaki Takeuchi; Klaus Strebel; Judith G Levin
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

Review 7.  Diversity of Immunoglobulin (Ig) Isotypes and the Role of Activation-Induced Cytidine Deaminase (AID) in Fish.

Authors:  Bhakti Patel; Rajanya Banerjee; Mrinal Samanta; Surajit Das
Journal:  Mol Biotechnol       Date:  2018-06       Impact factor: 2.695

8.  Optimization of apolipoprotein B mRNA editing by APOBEC1 apoenzyme and the role of its auxiliary factor, ACF.

Authors:  Ann Chester; Violetta Weinreb; Charles W Carter; Naveenan Navaratnam
Journal:  RNA       Date:  2004-07-23       Impact factor: 4.942

9.  The apolipoprotein B mRNA editing complex performs a multifunctional cycle and suppresses nonsense-mediated decay.

Authors:  Ann Chester; Angelika Somasekaram; Maria Tzimina; Adam Jarmuz; Jane Gisbourne; Raymond O'Keefe; James Scott; Naveenan Navaratnam
Journal:  EMBO J       Date:  2003-08-01       Impact factor: 11.598

10.  tadA, an essential tRNA-specific adenosine deaminase from Escherichia coli.

Authors:  Jeannette Wolf; André P Gerber; Walter Keller
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.